메뉴 건너뛰기




Volumn 30, Issue 10, 2009, Pages 1049-1059

Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON; RIBAVIRIN;

EID: 71949115845     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04123.x     Document Type: Article
Times cited : (16)

References (57)
  • 1
    • 0035811625 scopus 로고    scopus 로고
    • Hepatitis C virus infection
    • Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001 345 : 41 52.
    • (2001) N Engl J Med , vol.345 , pp. 41-52
    • Lauer, G.M.1    Walker, B.D.2
  • 2
    • 0030752667 scopus 로고    scopus 로고
    • Hepatitis C virus: Epidemiology and transmission
    • Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997 26 : 521 526.
    • (1997) Hepatology , vol.26 , pp. 521-526
    • Heintges, T.1    Wands, J.R.2
  • 3
    • 0033382086 scopus 로고    scopus 로고
    • Epidemiology of hepatitis C in the United States
    • Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999 107 : 2S 9S.
    • (1999) Am J Med , vol.107
    • Williams, I.1
  • 4
    • 0037223797 scopus 로고    scopus 로고
    • Prevalence of hepatitis C among psychiatric patients in the public sector
    • Dinwiddie SH, Shicker L, Newman T. Prevalence of hepatitis C among psychiatric patients in the public sector. Am J Psychiatry 2003 160 : 172 174.
    • (2003) Am J Psychiatry , vol.160 , pp. 172-174
    • Dinwiddie, S.H.1    Shicker, L.2    Newman, T.3
  • 5
    • 0030880597 scopus 로고    scopus 로고
    • Hepatitis C virus infection among institutionalised psychiatric patients: A regression analysis of indicators of risk
    • Cividini A, Pistorio A, Regazzetti A, et al. Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk. J Hepatol 1997 27 : 455 463.
    • (1997) J Hepatol , vol.27 , pp. 455-463
    • Cividini, A.1    Pistorio, A.2    Regazzetti, A.3
  • 6
    • 0027263876 scopus 로고
    • Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwan
    • Chang TT, Lin H, Yen YS, Wu HL. Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwan. J Med Virol 1993 40 : 170 173. (Pubitemid 23169747)
    • (1993) Journal of Medical Virology , vol.40 , Issue.2 , pp. 170-173
    • Chang, T.-T.1    Lin, H.2    Yen, L.-S.3    Wu, H.-L.4
  • 7
  • 8
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975 982.
    • (2002) N Engl J Med , vol.347 , pp. 975-982
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, K.R.3
  • 9
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
    • Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001 358 : 958 965.
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1    McHutchison, J.G.2    Gordon, S.C.3
  • 10
    • 0036788338 scopus 로고    scopus 로고
    • Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
    • McHutchison JG, Manns M, Patel K, et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002 123 : 1061 1069.
    • (2002) Gastroenterology , vol.123 , pp. 1061-1069
    • McHutchison, J.G.1    Manns, M.2    Patel, K.3
  • 12
    • 18344413225 scopus 로고    scopus 로고
    • Ribavirin may be an important factor in IFN-induced neuropsychiatric effects
    • Asnis GM, De La GR, Miller AH, Raison CL. Ribavirin may be an important factor in IFN-induced neuropsychiatric effects. J Clin Psychiatry 2004 65 : 581 582.
    • (2004) J Clin Psychiatry , vol.65 , pp. 581-582
    • Asnis, G.M.1    De La, G.R.2    Miller, A.H.3    Raison, C.L.4
  • 15
    • 0025921602 scopus 로고
    • Persistent neurotoxicity of systemically administered interferon-alpha
    • Meyers CA, Scheibel RS, Forman AD. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991 41 : 672 676.
    • (1991) Neurology , vol.41 , pp. 672-676
    • Meyers, C.A.1    Scheibel, R.S.2    Forman, A.D.3
  • 16
    • 15244363180 scopus 로고    scopus 로고
    • Depression during therapy with interferon alpha - How long should an antidepressant treatment last?
    • Nickel T, Sonntag A, Backmund M, Pollmacher T. Depression during therapy with interferon alpha - how long should an antidepressant treatment last? Pharmacopsychiatry 2005 38 : 102 104.
    • (2005) Pharmacopsychiatry , vol.38 , pp. 102-104
    • Nickel, T.1    Sonntag, A.2    Backmund, M.3    Pollmacher, T.4
  • 17
    • 27944470385 scopus 로고    scopus 로고
    • Interferon-induced depression and cognitive impairment in hepatitis C virus patients: A 72 week prospective study
    • Reichenberg A, Gorman JM, Dieterich DT. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study. AIDS 2005 3 : S174 8.
    • (2005) AIDS , vol.3 , pp. 174-8
    • Reichenberg, A.1    Gorman, J.M.2    Dieterich, D.T.3
  • 18
    • 0037308288 scopus 로고    scopus 로고
    • Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
    • Schaefer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003 37 : 443 451.
    • (2003) Hepatology , vol.37 , pp. 443-451
    • Schaefer, M.1    Schmidt, F.2    Folwaczny, C.3
  • 19
    • 0004235298 scopus 로고    scopus 로고
    • 4th edn, American Psychiatric Association. DSM-IV-TR. American Psychiatric Association. Washington, DC
    • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, DSM-IV-TR. American Psychiatric Association. Washington, DC, 2000.
    • (2000) Diagnostic and Statistical Manual of Mental Disorders
  • 21
    • 0018425438 scopus 로고
    • A new depression scale designed to be sensitive to change
    • Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 134 : 382 389.
    • (1979) Br J Psychiatry , vol.134 , pp. 382-389
    • Montgomery, S.A.1    Asberg, M.2
  • 22
    • 0000503515 scopus 로고
    • The brief psychiatric rating scale
    • Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962 10 : 799 812.
    • (1962) Psychol Rep , vol.10 , pp. 799-812
    • Overall, J.E.1    Gorham, D.R.2
  • 24
    • 34247550405 scopus 로고    scopus 로고
    • Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C
    • Raison CL, Woolwine BJ, Demetrashvili MF, et al. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther 2007 25 : 1163 1174.
    • (2007) Aliment Pharmacol Ther , vol.25 , pp. 1163-1174
    • Raison, C.L.1    Woolwine, B.J.2    Demetrashvili, M.F.3
  • 25
    • 0033054813 scopus 로고    scopus 로고
    • EASL consensus statement - International consensus conference on hepatitis C
    • EASL
    • EASL. EASL Consensus Statement - International Consensus Conference on Hepatitis C. J Hepatol 1999 30 : 956 961.
    • (1999) J Hepatol , vol.30 , pp. 956-961
  • 26
    • 0031584956 scopus 로고    scopus 로고
    • Management of hepatitis C: NIH consensus statement
    • NIH
    • NIH. Management of Hepatitis C: NIH Consensus Statement. Hepatology 1997 15 : 1 41.
    • (1997) Hepatology , vol.15 , pp. 1-41
  • 27
    • 0035913229 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis C in active drug users
    • Davis GL, Rodrigue JR. Treatment of chronic hepatitis C in active drug users. N Engl J Med 2001 345 : 215 217.
    • (2001) N Engl J Med , vol.345 , pp. 215-217
    • Davis, G.L.1    Rodrigue, J.R.2
  • 28
    • 0035913261 scopus 로고    scopus 로고
    • Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?
    • Edlin BR, Seal KH, Lorvick J, et al. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? N Engl J Med 2001 345 : 211 215.
    • (2001) N Engl J Med , vol.345 , pp. 211-215
    • Edlin, B.R.1    Seal, K.H.2    Lorvick, J.3
  • 29
    • 4544228944 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis C in patients with drug dependence: Time to change the rules?
    • Schaefer M, Heinz A, Backmund M. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 2004 99 : 1167 1175.
    • (2004) Addiction , vol.99 , pp. 1167-1175
    • Schaefer, M.1    Heinz, A.2    Backmund, M.3
  • 30
    • 0037119025 scopus 로고    scopus 로고
    • Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals
    • Taylor LE, Costello T, Alt E, Yates G, Tashima K. Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals. AIDS 2002 16 : 1700 1701.
    • (2002) AIDS , vol.16 , pp. 1700-1701
    • Taylor, L.E.1    Costello, T.2    Alt, E.3    Yates, G.4    Tashima, K.5
  • 31
    • 0033542853 scopus 로고    scopus 로고
    • Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders
    • Pariante CM, Orru MG, Baita A, Farci MG, Carpiniello B. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999 354 : 131 132.
    • (1999) Lancet , vol.354 , pp. 131-132
    • Pariante, C.M.1    Orru, M.G.2    Baita, A.3    Farci, M.G.4    Carpiniello, B.5
  • 32
    • 33644747709 scopus 로고    scopus 로고
    • Hepatitis C treatment of veterans with psychiatric illness
    • Rifai MA, Loftis JM, Hauser P. Hepatitis C treatment of veterans with psychiatric illness. Am J Gastroenterol 2006 101 : 673 674.
    • (2006) Am J Gastroenterol , vol.101 , pp. 673-674
    • Rifai, M.A.1    Loftis, J.M.2    Hauser, P.3
  • 33
    • 36348986800 scopus 로고    scopus 로고
    • Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects
    • Schaefer M, Hinzpeter A, Mohmand A, et al. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Hepatology 2007 46 : 991 998.
    • (2007) Hepatology , vol.46 , pp. 991-998
    • Schaefer, M.1    Hinzpeter, A.2    Mohmand, A.3
  • 34
    • 0028858952 scopus 로고
    • Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness
    • Van Thiel DH, Friedlander L, Molloy PJ, Fagiuoli S, Kania RJ, Caraceni P. Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness. Eur J Gastroenterol Hepatol 1995 7 : 165 168.
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 165-168
    • Van Thiel, D.H.1    Friedlander, L.2    Molloy, P.J.3    Fagiuoli, S.4    Kania, R.J.5    Caraceni, P.6
  • 35
    • 0036430340 scopus 로고    scopus 로고
    • A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C
    • Hauser P, Khosla J, Aurora H, et al. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 2002 7 : 942 947.
    • (2002) Mol Psychiatry , vol.7 , pp. 942-947
    • Hauser, P.1    Khosla, J.2    Aurora, H.3
  • 36
    • 0037872269 scopus 로고    scopus 로고
    • Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy
    • Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 2003 64 : 708 714.
    • (2003) J Clin Psychiatry , vol.64 , pp. 708-714
    • Kraus, M.R.1    Schafer, A.2    Faller, H.3    Csef, H.4    Scheurlen, M.5
  • 37
    • 33748257103 scopus 로고    scopus 로고
    • Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): Results from a prospective study
    • Lieb K, Engelbrecht MA, Gut O, et al. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study. Eur Psychiatry 2006 21 : 204 210.
    • (2006) Eur Psychiatry , vol.21 , pp. 204-210
    • Lieb, K.1    Engelbrecht, M.A.2    Gut, O.3
  • 38
    • 0031914489 scopus 로고    scopus 로고
    • Interferon alpha-induced depression in chronic hepatitis C patients: Comparison between different types of interferon alpha
    • Malaguarnera M, Di FI, Restuccia S, Pistone G, Ferlito L, Rampello L. Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 1998 37 : 93 7.
    • (1998) Neuropsychobiology , vol.37 , pp. 93-7
    • Malaguarnera, M.1    Di, F.I.2    Restuccia, S.3    Pistone, G.4    Ferlito, L.5    Rampello, L.6
  • 39
    • 33750342122 scopus 로고    scopus 로고
    • Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: Comparison between interferon-alpha-2a and interferon-alpha-2b
    • Neri S, Pulvirenti D, Bertino G. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b. Clin Drug Investig 2006 26 : 655 662.
    • (2006) Clin Drug Investig , vol.26 , pp. 655-662
    • Neri, S.1    Pulvirenti, D.2    Bertino, G.3
  • 40
    • 9944223329 scopus 로고    scopus 로고
    • Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C
    • Raison CL, Broadwell SD, Borisov AS, et al. Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun 2005 19 : 23 7.
    • (2005) Brain Behav Immun , vol.19 , pp. 23-7
    • Raison, C.L.1    Broadwell, S.D.2    Borisov, A.S.3
  • 41
    • 13844306621 scopus 로고    scopus 로고
    • Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction
    • Raison CL, Borisov AS, Broadwell SD, et al. Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 2005 66 : 41 8.
    • (2005) J Clin Psychiatry , vol.66 , pp. 41-8
    • Raison, C.L.1    Borisov, A.S.2    Broadwell, S.D.3
  • 42
    • 0037266123 scopus 로고    scopus 로고
    • Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: A prospective study
    • Horikawa N, Yamazaki T, Izumi N, Uchihara M. Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study. Gen Hosp Psychiatry 2003 25 : 34 8.
    • (2003) Gen Hosp Psychiatry , vol.25 , pp. 34-8
    • Horikawa, N.1    Yamazaki, T.2    Izumi, N.3    Uchihara, M.4
  • 43
    • 0036186518 scopus 로고    scopus 로고
    • Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
    • Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002 35 : 704 708.
    • (2002) Hepatology , vol.35 , pp. 704-708
    • Bernstein, D.1    Kleinman, L.2    Barker, C.M.3    Revicki, D.A.4    Green, J.5
  • 44
    • 33646476276 scopus 로고    scopus 로고
    • Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C
    • Hollander A, Foster GR, Weiland O. Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C. Scand J Gastroenterol 2006 41 : 577 585.
    • (2006) Scand J Gastroenterol , vol.41 , pp. 577-585
    • Hollander, A.1    Foster, G.R.2    Weiland, O.3
  • 45
    • 31144436818 scopus 로고    scopus 로고
    • Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan
    • Kang SC, Hwang SJ, Lee SH, Chang FY, Lee SD. Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan. World J Gastroenterol 2005 11 : 7494 7498.
    • (2005) World J Gastroenterol , vol.11 , pp. 7494-7498
    • Kang, S.C.1    Hwang, S.J.2    Lee, S.H.3    Chang, F.Y.4    Lee, S.D.5
  • 46
    • 33745176622 scopus 로고    scopus 로고
    • Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with pegylated interferon alpha-2b and ribavirin
    • Mathew A, Peiffer LP, Rhoades K, McGarrity TJ. Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with pegylated interferon alpha-2b and ribavirin. Health Qual Life Outcomes 2006 4 : 30.
    • (2006) Health Qual Life Outcomes , vol.4 , pp. 30
    • Mathew, A.1    Peiffer, L.P.2    Rhoades, K.3    McGarrity, T.J.4
  • 47
    • 0035133564 scopus 로고    scopus 로고
    • The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity
    • McHutchison JG, Ware JE Jr., Bayliss MS, et al. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 2001 34 : 140 147.
    • (2001) J Hepatol , vol.34 , pp. 140-147
    • McHutchison, J.G.1    Ware, Jr.J.E.2    Bayliss, M.S.3
  • 48
    • 84891685662 scopus 로고    scopus 로고
    • Health benefits of antiviral therapy for mild chronic hepatitis C: Randomised controlled trial and economic evaluation
    • Wright M, Grieve R, Roberts J, Main J, Thomas HC. Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. Health Technol Assess 2006 10 : 1 113.
    • (2006) Health Technol Assess , vol.10 , pp. 1-113
    • Wright, M.1    Grieve, R.2    Roberts, J.3    Main, J.4    Thomas, H.C.5
  • 49
    • 30544445602 scopus 로고    scopus 로고
    • Cytokines sing the blues: Inflammation and the pathogenesis of depression
    • Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006 27 : 24 31.
    • (2006) Trends Immunol , vol.27 , pp. 24-31
    • Raison, C.L.1    Capuron, L.2    Miller, A.H.3
  • 51
    • 0034496202 scopus 로고    scopus 로고
    • Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy
    • Weissenborn K, Berding G, Kostler H. Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy. Metab Brain Dis 2000 15 : 173 178.
    • (2000) Metab Brain Dis , vol.15 , pp. 173-178
    • Weissenborn, K.1    Berding, G.2    Kostler, H.3
  • 52
    • 7244260730 scopus 로고    scopus 로고
    • Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy
    • Weissenborn K, Krause J, Bokemeyer M, et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004 41 : 845 851.
    • (2004) J Hepatol , vol.41 , pp. 845-851
    • Weissenborn, K.1    Krause, J.2    Bokemeyer, M.3
  • 53
    • 0036156909 scopus 로고    scopus 로고
    • Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease
    • Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002 35 : 433 439.
    • (2002) Hepatology , vol.35 , pp. 433-439
    • Forton, D.M.1    Thomas, H.C.2    Murphy, C.A.3
  • 55
    • 0035133903 scopus 로고    scopus 로고
    • Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C
    • Fontana RJ, Moyer CA, Sonnad S, et al. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol 2001 96 : 170 178.
    • (2001) Am J Gastroenterol , vol.96 , pp. 170-178
    • Fontana, R.J.1    Moyer, C.A.2    Sonnad, S.3
  • 56
    • 33947425672 scopus 로고    scopus 로고
    • The effects of HCV infection and management on health-related quality of life
    • DOI 10.1002/hep.21565
    • Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology 2007 45 : 806 816. (Pubitemid 46450632)
    • (2007) Hepatology , vol.45 , Issue.3 , pp. 806-816
    • Younossi, Z.1    Kallman, J.2    Kincaid, J.3
  • 57
    • 17144384773 scopus 로고    scopus 로고
    • Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
    • Kraus MR, Schafer A, Csef H, Scheurlen M. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J Gastroenterol 2005 11 : 1769 1774.
    • (2005) World J Gastroenterol , vol.11 , pp. 1769-1774
    • Kraus, M.R.1    Schafer, A.2    Csef, H.3    Scheurlen, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.